Therma Bright (TSE:THRM) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Therma Bright Inc. celebrates the successful initial clinical trial results of the PREVA™ ischemic stroke device, developed by its investment partner Inretio, which were presented at the BRAIN Conference 2024. The device promises to revolutionize stroke care by improving patient recovery outcomes, marking a significant milestone for Inretio’s clinical program.
For further insights into TSE:THRM stock, check out TipRanks’ Stock Analysis page.
